HPC Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 535217 | NSE: | Agriculture | Small Cap

HPC Biosciences Share Price

25.68 0.00 0.00%
as on 29-Jul'24 16:01

DeciZen - make an informed investing decision on HPC Biosciences

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

HPC Biosciences stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
409.9 Cr.
52-wk low:
25.7
52-wk high:
25.7

Is HPC Biosciences Ltd an attractive stock to invest in?

1. Is HPC Biosciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that HPC Biosciences Ltd is a average quality company.

2. Is HPC Biosciences Ltd undervalued or overvalued?

The key valuation ratios of HPC Biosciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is HPC Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of HPC Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of HPC Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
HPC Biosciences Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 125%18.4%4.5%2.6%1.7%1.9%0.8%1.9%1.1%3.7%-
Value Creation
Index
7.90.3-0.7-0.8-0.9-0.9-0.9-0.9-0.9-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.94.83.53.11.92.321.61.22.30
Sales YoY Gr.-64.1%-27.3%-10.7%-39.5%20.9%-13.7%-18%-25%90.8%-
Adj EPS 0.90.20.10000000.10
YoY Gr.--78.2%-57.9%-50%-25%0%-66.7%200%-33.3%250%-
BVPS (₹) 1.41.71.81.81.91.91.9222.12.1
Adj Net
Profit
3.131.20.70.50.50.20.60.31.20
Cash Flow from Ops. -0.43.440.2-0.21.10.11.20.81.4-
Debt/CF from Ops. 000.10000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -2.6%4.1%5.5%90.8%
Adj EPS -24.4%18.5%91.3%250%
BVPS4.6%2%2.2%3.5%
Share Price -6.8% -1.3% -1% -2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on
Equity %
125.818.34.42.41.51.70.61.81.13.60
Op. Profit
Mgn %
109.690.373.764.693.860.948.575.372.370.877.6
Net Profit
Mgn %
105.262.535.722.824.722.510.134.628.151.20
Debt to
Equity
00000000000
Working Cap
Days
2286671,5872,1454,1223,7884,7636,0588,3824,5841,058
Cash Conv.
Cycle
711251562057017781,0491,3981,8879961,038

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 0.00%

Sales growth has been subdued in last 3 years 5.50%

Sales growth is not so good in last 4 quarters at -8.77%

Latest Financials - HPC Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.2 -
BVPS (₹.) 2.1 -
Reserves (₹ Cr.) 17 -
P/BV 12.48 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 25.68 / 25.68
All Time Low / High (₹) 3.73 / 75.75
Market Cap (₹ Cr.) 410
Equity (₹ Cr.) 16
Face Value (₹) 1
Industry PE 44.2

Management X-Ray of HPC Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of HPC Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Sales3533222212
Operating Expenses 0011011001
Manufacturing Costs0000000000
Material Costs-1000-100000
Employee Cost 0000000000
Other Costs 0000000000
Operating Profit 3432211112
Operating Profit Margin (%) 109.6%90.3%73.7%64.6%93.8%60.9%48.5%75.3%72.3%70.8%
Other Income 0000000000
Interest 0000000000
Depreciation 0111111111
Exceptional Items 0000000000
Profit Before Tax 3311110101
Tax 0000000000
Profit After Tax 3311010101
PAT Margin (%) 105.2%62.5%35.7%22.8%24.7%22.5%10.1%34.6%28.1%51.2%
Adjusted EPS (₹)0.90.20.10.00.00.00.00.00.00.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21

Equity and Liabilities

Shareholders Fund 5282930303131313233
Share Capital 2161616161616161616
Reserves 3121314141515151617
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables0000000000
Others Liabilities 0000000100
Total Liabilities 5282930303131323233

Fixed Assets

Gross Block1121212121212121212
Accumulated Depreciation0134677899
Net Fixed Assets111108765443
CWIP 0000000000
Investments 0230000000
Inventories1111111111
Trade Receivables0102345556
Cash Equivalents 0101100000
Others Assets2121618182020212223
Total Assets 5282930303131323233

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Cash Flow From Operating Activity 0340010111
PBT 3311110101
Adjustment 0111111110
Changes in Working Capital -4-11-2-2-0-1-0-0-0
Tax Paid 0000000000
Cash Flow From Investing Activity -1-23-510-20-1-10
Capex -1-1100000000
Net Investments 0-202000000
Others 0-10-4-20-20-1-10
Cash Flow From Financing Activity 22000000000
Net Proceeds from Shares 22000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 01000-10001
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Ratios
ROE (%)125.818.474.412.441.561.680.641.781.073.62
ROCE (%)124.9518.434.452.61.731.880.781.861.143.69
Asset Turnover Ratio1.190.290.120.10.060.070.060.050.040.07
PAT to CFO Conversion(x)0140N/A1N/A1N/A1
Working Capital Days
Receivable Days445502345125778481,1921,630888
Inventory Days98709888188201201206256108
Payable Days0000000000

HPC Biosciences Ltd Stock News

HPC Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of HPC Biosciences on 29-Jul-2024 16:01 is ₹25.68.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Jul-2024 16:01 the market cap of HPC Biosciences stood at ₹409.9.
The latest P/E ratio of HPC Biosciences as of 29-Jul-2024 16:01 is 0.00.
The latest P/B ratio of HPC Biosciences as of 29-Jul-2024 16:01 is 12.48.
The 52-week high of HPC Biosciences is ₹25.68 and the 52-week low is ₹25.68.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of HPC Biosciences is ₹0.21 ( Cr.) .

About HPC Biosciences Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.